Tel Stimos

WSJ's Take On the Week

Biotech’s rally tests the promise of cancer breakthroughs

Investors must decide whether excitement around cancer vaccines, AI and new drug platforms reflects durable growth or inflated valuations.

Sep 13, 2026 · 32 min